PRECSIT and breast cancer: In BRCA1-mut breast cancer, KANK4, MFGE8, LINC00346, and A100A1 were upregulated (more than 3-fold change), and in BRCA2-mut breast cancers, MAGEA4 was highly expressed (more than 4-fold change) (Figure 1B).